CpG island hypermethylation ofBRCA1and loss of pRb as co-occurring events in basal/triple-negative breast cancer-Reference-Cited by-同舟云学术

CpG island hypermethylation ofBRCA1and loss of pRb as co-occurring events in basal/triple-negative breast cancer

Published:2011-05 Issue:5 Volume:6 Page:638-649
ISSN:1559-2294
Container-title:Epigenetics
language:en
Short-container-title:Epigenetics

Author:

Stefansson Olafur Andri,Jonasson Jon Gunnlaugur,Olafsdottir Kristrun,Hilmarsdottir Holmfridur,Olafsdottir Gudridur,Esteller Manel,Johannsson Oskar Thor,Eyfjord Jorunn Erla

Publisher

Informa UK Limited

Subject

Cancer Research,Molecular Biology

Link

http://www.tandfonline.com/doi/pdf/10.4161/epi.6.5.15667

Reference46 articles.

1. Triple-Negative Breast Cancer: Risk Factors to Potential Targets

2. Poly(ADP-Ribose) Polymerase Inhibition: “Targeted” Therapy for Triple-Negative Breast Cancer

3. Repeated observation of breast tumor subtypes in independent gene expression data sets

4. Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma

5. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma;Clinical Cancer Research;2024-06-05

2. Concurrent RB1 loss andBRCA-deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinoma;2023-11-10

3. Role of epigenetics variation with focus on DNA methylation in triple-negative breast cancer patients;Archives of Medicine and Health Sciences;2023

4. Role of Epigenetics Variation with Focus on DNA Methylation in Triple-Negative Breast Cancer Patients;Archives of Medicine and Health Sciences;2023-01

5. Loss of Brca1 and Trp53 in adult mouse mammary ductal epithelium results in development of hormone receptor-positive or hormone receptor-negative tumors, depending on inactivation of Rb family proteins;Breast Cancer Research;2022-11-04